Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global upper respiratory tract infection treatment market size attained a value of USD 1.81 billion in 2023. The market is likely to grow at a CAGR of 3.6% during the forecast period of 2024-2032. With this growth rate, the market is anticipated to attain a value of USD 2.48 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
An upper respiratory tract infection (URTI) is an illness, which is the result of an acute infection involving a person’s upper respiratory tract like the nose, sinuses, pharynx, or larynx. The infection commonly includes nasal obstruction, sore throat, tonsillitis, pharyngitis, laryngitis, otitis media, and the common cold. This can be treated using various drugs, targeting disease-causing pathogens like bacteria and viruses.
The signs and symptoms of the condition include fever, cough, runny nose, hoarse voice, fatigue, vomiting, unconsciousness, difficulty in breathing, retractions, especially in children, and stridor, among others. While the symptoms usually get better in one to two weeks, in some cases the condition might get worse if the symptoms do not subside within this timeline. In worst case scenario, the infection might lead to bronchitis or pneumonia.
Upper respiratory tract infection can affect anyone, but some people are more prone to the condition, especially children. Children are at a higher risk of catching the infection since the possibility of transmission is much higher. Children do no follow regular hygiene habits, like washing hands, and are more likely to carry the germs in their hands and put their fingers in their mouth, nose, and/or eyes, enabling the germs to enter the body. Other than children, people with lung or heart disorders are also vulnerable to the condition. Weak immune system also makes people more prone to upper respiratory tract infection.
The market can be categorised into segments like type, route of administration, distribution channel, and major regions.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Type
Market Breakup by Route of Administration
Market by Distribution Channel
Market Breakup by Region
The growing incidence of upper respiratory tract infections, the development of new drugs, and the increasing demand for over-the-counter drugs is aiding the growth of the upper respiratory tract infection treatment market globally. With the advancement in technology and development in the treatment of upper respiratory tract infection, the market is witnessing an increased growth. Further, the growing awareness regarding the treatment and the rising disposable income, especially in emerging economies, are expected to drive the industry growth over the forecast period.
The antibiotics segment, among other types, dominated the global market in 2023, owing to its easy availability and effective results. Region-wise, while North America accounted for the highest share in the market in 2023, the Asia Pacific region is expected to grow at the fastest rate over the forecast period owing to the growing population and increased expenditure on health care services in the region.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The report presents a detailed analysis of the following key players in the global upper respiratory tract infection treatment market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Route of Administration |
|
Breakup by Distribution Channel |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Upper Respiratory Tract Infection Treatment Market Size
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!
The market size attained a value of USD 1.81 billion in 2023, driven by the rising prevalence of lung disorders.
The market is likely to grow at a CAGR of 3.6% during the forecast period of 2024-2032 to attain a value of USD 2.48 billion by 2032.
The major drivers of the market include the growing incidence of upper respiratory tract infections, development of new drugs, growing awareness regarding the treatment, rising disposable income, and advancement in technology.
They key trends in the market include the rise in the demand for and availability of over-the-counter drugs, and the advent of biologics.
The major regional markets include North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
The types can be divided into nonsteroidal anti-inflammatory drugs (NSAIDs) And nasal decongestants, among others.
The routes of administration include oral, nasal, and parenteral routes.
The distribution channels in the market include hospital pharmacies and online pharmacies, among others.
The key players in the market include GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Pfizer Inc., Cipla Limited, Lupin Limited, Merck & Co., Inc., Alcon, Inc., Teva Pharmaceuticals, and Sandoz, Inc., among others.
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Pricing Plans
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124